Login
Who's Online
We have 124 guests and no members online
Statistics
- Users 5508
- Articles 727
- Articles View Hits 16881026
Why Use This Site for Advertisement?
Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy. |
|
Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology. The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation. |
Advertisement Opportunities
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
1 | Full banner | Located in rotation with other banners on all pages, including the home page |
2 | Home page banner or text links | Located only on the home page. Always visible in 1st or 2nd news item in center of the home page |
3 | Cube banner | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
4 | Text links | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- Real-World Experience With Duchenne Muscular Dystrophy Gene Therapy - CGTLive™
Sat, 07 Sep 2024 15:08:4 GMT - Stoke Therapeutics: The First Gene Therapy For Dravet Syndrome - Seeking Alpha
Sat, 07 Sep 2024 10:03:2 GMT - Adapting to Growth: Innovative Lab Solutions for the Evolving Cell and Gene Therapy Market - BioProcess Insider
Sat, 07 Sep 2024 04:19:1 GMT - Gene therapy for LCA1 improves vision by up to 10,000-fold - Drug Discovery & Development
Sat, 07 Sep 2024 01:16:4 GMT - Gene therapy trial facilitates major vision improvement - European Pharmaceutical Review
Fri, 06 Sep 2024 18:41:0 GMT - Gene therapy restores vision in first-ever trial for rare, inherited blindness - University of Florida
Fri, 06 Sep 2024 18:37:3 GMT - Gene therapy may reverse rare cause of vision loss - UPI News
Fri, 06 Sep 2024 15:57:4 GMT - Gene therapy restores sight with up to 10,000-fold vision improvement - Interesting Engineering
Fri, 06 Sep 2024 15:34:0 GMT - Novartis to License VYGR's Capsid for Gene Therapy in Neurology - Yahoo Finance
Fri, 06 Sep 2024 15:22:0 GMT - Gene therapy improves vision in Leber congenital amaurosis - Health Tech World
Fri, 06 Sep 2024 15:06:2 GMT - Marking World Duchenne Muscular Dystrophy Day, Genethon Reaffirms Its Commitment to Helping Patients for 35 Years and Provides an Update on Its Promising Gene Therapy Drug Candidate for This Fatal Disease - businesswire.com
Fri, 06 Sep 2024 11:30:0 GMT - Breakthrough in cancer treatment: How gene therapy can stop growth of cancer cells - The Indian Express
Fri, 06 Sep 2024 11:03:5 GMT - The rising demand for lentiviral vectors for in vivo gene therapy - Drug Target Review
Fri, 06 Sep 2024 11:03:0 GMT - 100-fold improvement in sight seen after gene therapy trial - Medical Xpress
Fri, 06 Sep 2024 00:30:0 GMT - Gene therapy biotech Medera looks back to SPAC as way to go public - Fierce Biotech
Thu, 05 Sep 2024 16:50:0 GMT